| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $234.7M | +10.6% |
| Cost of Revenue | $261.4M | +14.3% |
| Gross Profit | -$26.8M | -61.1% |
| R&D Expense | $86.2M | -18.0% |
| SG&A Expense | $203.3M | -1.3% |
| Operating Income | -$667.7M | -49.6% |
| Interest Expense | $3.2M | +13.1% |
| Pre-tax Income | -$598.0M | -143.7% |
| Income Tax | -$49.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $123.9M | -69.1% |
| Accounts Receivable | $42.6M | +60.8% |
| Inventory | $13.7M | -59.2% |
| Current Assets | $212.6M | -56.0% |
| Total Assets | $490.9M | -11.4% |
| Current Liabilities | $144.3M | +42.5% |
| Long-term Debt | $11.0M | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$319.2M | -67.6% |
| Capital Expenditures | $7.2M | -23.9% |
| Investing Cash Flow | -$141.3M | -579.9% |
| Financing Cash Flow | $197.3M | -60.0% |
| Free Cash Flow | -$326.3M | -63.3% |
| — |
| Net Income | -$549.0M | -123.7% |
| EPS (Basic) | -$1.63 | +28.2% |
| EPS (Diluted) | -$1.63 | +28.2% |
| Total Liabilities |
| $237.2M |
| +42.9% |
| Stockholders' Equity | $253.7M | -34.6% |